TY - JOUR
T1 - Healthcare personnel in 2016–2019 prospective cohort infrequently got vaccinated, worked while ill, and frequently used antibiotics rather than antivirals against viral influenza illnesses
AU - Azziz-Baumgartner, Eduardo
AU - Neyra, Joan
AU - Yau, Tat S.
AU - Soto, Giselle
AU - Owusu, Daniel
AU - Zhang, Chao
AU - Romero, Candice
AU - Yoo, Young M.
AU - Gonzales, Miriam
AU - Tinoco, Yeny
AU - Silva, María
AU - Bravo, Eduar
AU - Serrano, Nancy Rojas
AU - Matos, Eduardo
AU - Chavez-Perez, Victor
AU - Castro, Juan Carlos
AU - Esther Castillo, Maria
AU - Porter, Rachael
AU - Munayco, Cesar
AU - Rodriguez, Angel
AU - Levine, Min Z.
AU - Prouty, Michael
AU - Thompson, Mark G.
AU - Arriola, Carmen Sofia
N1 - Publisher Copyright:
© 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
PY - 2023/9
Y1 - 2023/9
N2 - Background: Uncertainty about risk of illness and the value of influenza vaccines negatively affects vaccine uptake among persons targeted for influenza vaccination. Methods: During 2016–2019, we followed a cohort of healthcare personnel (HCP) targeted for free-of-charge influenza vaccination in five Lima hospitals to quantify risk of influenza, workplace presenteeism (coming to work despite illness), and absenteeism (taking time off from work because of illness). The HCP who developed acute respiratory illnesses (ARI) (≥1 of acute cough, runny nose, body aches, or feverishness) were tested for influenza using reverse-transcription polymerase chain reaction (rt-PCR). Findings: The cohort (2968 HCP) contributed 950,888 person-days. Only 36 (6%) of 605 HCP who participated every year were vaccinated. The HCP had 5750 ARI and 147 rt-PCR-confirmed influenza illnesses. The weighted incidence of laboratory-confirmed influenza was 10.0/100 person-years; 37% used antibiotics, and 0.7% used antivirals to treat these illnesses. The HCP with laboratory-confirmed influenza were present at work while ill for a cumulative 1187 hours. Interpretation: HCP were frequently ill and often worked rather than stayed at home while ill. Our findings suggest the need for continuing medical education about the risk of influenza and benefits of vaccination and stay-at-home-while-ill policies.
AB - Background: Uncertainty about risk of illness and the value of influenza vaccines negatively affects vaccine uptake among persons targeted for influenza vaccination. Methods: During 2016–2019, we followed a cohort of healthcare personnel (HCP) targeted for free-of-charge influenza vaccination in five Lima hospitals to quantify risk of influenza, workplace presenteeism (coming to work despite illness), and absenteeism (taking time off from work because of illness). The HCP who developed acute respiratory illnesses (ARI) (≥1 of acute cough, runny nose, body aches, or feverishness) were tested for influenza using reverse-transcription polymerase chain reaction (rt-PCR). Findings: The cohort (2968 HCP) contributed 950,888 person-days. Only 36 (6%) of 605 HCP who participated every year were vaccinated. The HCP had 5750 ARI and 147 rt-PCR-confirmed influenza illnesses. The weighted incidence of laboratory-confirmed influenza was 10.0/100 person-years; 37% used antibiotics, and 0.7% used antivirals to treat these illnesses. The HCP with laboratory-confirmed influenza were present at work while ill for a cumulative 1187 hours. Interpretation: HCP were frequently ill and often worked rather than stayed at home while ill. Our findings suggest the need for continuing medical education about the risk of influenza and benefits of vaccination and stay-at-home-while-ill policies.
KW - acute respiratory illness
KW - healthcare personnel
KW - influenza
KW - influenza vaccine
UR - https://www.scopus.com/pages/publications/85170038270
U2 - 10.1111/irv.13189
DO - 10.1111/irv.13189
M3 - Artículo
C2 - 37693773
AN - SCOPUS:85170038270
SN - 1750-2640
VL - 17
JO - Influenza and other Respiratory Viruses
JF - Influenza and other Respiratory Viruses
IS - 9
M1 - e13189
ER -